rss
Br J Ophthalmol 1991;75:356-358 doi:10.1136/bjo.75.6.356
  • Research Article

Yellow mercuric oxide: a treatment of choice for phthiriasis palpebrarum.

  1. I Ashkenazi,
  2. H R Desatnik and
  3. F A Abraham
  1. Department of Ophthalmology, Goldschleger Eye Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel.

      Abstract

      Thirty-five patients presenting with phthiriasis palpebrarum were all treated with a regimen of 1% yellow oxide of mercury ointment four times daily for 14 days. At the conclusion of treatment there was complete resolution of the signs and symptoms of the disease. No side effects due to the treatment were reported or detected. We have shown that 1% mercuric oxide ointment is both a safe and effective treatment for phthiriasis palpebrarum. We recommend it as the treatment of choice.

      Register for free content

      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.